TLR3-dependent regulation of cytokines in human mesangial cells: A novel role for IP-10 and TNF-α in hepatitis c-associated glomerulonephritis

American Journal of Physiology - Renal Physiology

Volumn 301, Issue 1, 2011, Pages

  Merkle, Monika ^a   Ribeiro, Andrea ^b   Wörnle, Markus ^b  

^a Klinikum Traunstein   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Toll like receptor

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON; INTERLEUKIN 1BETA; MESSENGER RNA; POLYINOSINIC POLYCYTIDYLIC ACID; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 1; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 2; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; GLOMERULONEPHRITIS; HEPATITIS C; HUMAN; HUMAN CELL; MESANGIUM CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UPREGULATION;

EID: 79960050345     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00083.2011     Document Type: Article

References (30)

1. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF- B by toll-like receptor 3. Nature 413: 732-738, 2001.
2. Al-Lamki RS, Wang J, Vandenabeele P, Bradley JA, Thiru S, Luo D, Min W, Pober JS, Bradley JR. TNFR1- and TNFR2-mediated signalling pathways in human kidney are cell-type specific and differentially contribute to renal injury. FASEB J 19: 1637-1645, 2005.
3. Antonelli A, Ferri C, Fallahi P, Ferrari SM, Sebastiani M, Ferrari D, Giunti M, Frascerra S, Tolari S, Franzoni F, Galetta F, Marchi S, Ferrannini E. High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection. Am J Gastroenterol 103: 2488-2494, 2008.
4. Aringer M, Houssiau F, Gordon C, Graninger WB, Voll RE, Rath E, Steiner G, Smolen JS. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematodes: longterm follow-up of 13 patients. Rheumatology 48: 1451-1454, 2009.
5. Banas B, Wörnle M, Berger T, Nelson PJ, Cohen CD, Kretzler M, Pfirstinger J, Mack M, Lipp M, Gröne HJ, Schlöndorff D. Roles of SLC/CCL21 and CCR7 in human kidney for mesangial proliferation, migration, apoptosis, and tissue homeostasis. J Immunol 168: 4301-4307, 2002.
6. Ernandez T, Mayadas TN. Immunoregulatory role of TNFα in inflammatory kidney diseases. Kidney Int 76: 262-276, 2009.
7. Glass WG, Chen BP, Liu MT, Lane TE. Mouse hepatitis virus infection of the central nervous system: chemokine-mediated regulation of host defense and disease. Viral Immunol 15: 261-272, 2002.
8. Heeg K, Reimann J, Kabelitz D, Hardt C, Wagner H. A rapid colorimetric assay for the determination of IL-2-producing helper T cell frequencies. J Immunol Methods 77: 237-246, 1985.
9. Huugen D, Cohen Tervaert JW, Heeringa P. TNF-alpha bioactivityinhibiting therapy in ANCA-associated vasculitis: clinical and experimental considerations. Clin J Am Soc Nephrol 1: 1100-1107, 2006.
10. Joy MS, Gipson DS, Powell L, MacHardy J, Jennette JC, Vento S, Pan C, Savin V, Eddy A, Fogo AB, Kopp JB, Cattran D, Trochtman H. Phase 1 trial of adalimumab in focal segmental glomerulosclerosis (FSGS): II. report of the FONT study group. Am J Kidney Dis 55: 50-60, 2010.
11. Lanford RE, Guerra B, Chavez D, Bigger C, Brasky KM, Wang XH, Ray SC, Thomas DL. Cross-genotype immunity to hepatitis C virus. J Virol 78: 1575-1581, 2004.
12. Malmgaard L. Induction and regulation of IFNs during viral infections. J Interferon Cytokine Res 24: 439-454, 2004.
13. Masciopinto F, Giovani C, Campagnoli S, Galli-Stampino L, Colombatto P, Brunetto M, Yen TS, Houghton M, Pileri P, Abrignani S. Association of hepatitis C virus envelope proteins with exosomes. Eur J Immunol 34: 2834-2842, 2004.
14. Matsukura S, Kokubu F, Kurokawa M, Kawaguchi M, Ieki K, Kuga H, Odaka M, Suzuki S, Watanabe S, Homma T, Takeuchi H, Nohtomi K, Adachi M. Role of RIG-I, MDA-5, and PKR on the expression of inflammatory chemokines induced by synthetic dsRNA in airway epithelial cells. Int Arch Allergy Immunol 143, Suppl 1: 80-83, 2007.
15. Matz M, Beyer J, Wunsch D, Mashreghi MF, Seiler M, Pratschke J, Babel N, Volk HD, Reinke P, Kotsch K. Early post-transplant urinary IP-10 expression after kidney transplantation is predictive of short- and long-term graft function. Kidney Int 69: 1683-1690, 2006.
16. Missale G, Ferrari C, Fiaccadori F. Cytokine mediators in acute inflammation and chronic course of viral hepatitis. Ann Ital Med Int 10: 14-18, 1995.
17. Neuman MG, Benhamou JP, Bourliere M, Ibrahim A, Malkiewicz I, Asselah T, Martinot-Peignoux M, Shear NH, Kat GG, Akremi R, Benali S, Boyer N, Lecomte L, Le Breton V, Le Guludec G, Marcellin P. Serum tumor necrosis factor-alpha and transforming growth factor-beta levels in chronic hepatitis c patients are immunomodulated by therapy. Cytokine 17: 108-117. 2002.
18. Qi XF, Kim DH, Yoon YS, Jin D, Huang XZ, Li JH, Deung YK, Lee KJ. Essential involvement of cross-talk between IFN-gamma and TNFalpha in CXCL10 production in human THP-1 monocytes. J Cell Physiol 220: 690-697, 2009.
19. Rotondi M, Rosati A, Buonamano A, Lasagni L, Lazzeri E, Pradella F, Fossombroni V, Cirami C, Liotta F, La Villa G, Serio M, Bertoni E, Salvadori M, Romagnani P. High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of renal allograft failure. Am J Transplant 4: 1466-1474, 2004.
20. Satchell SC, Buchatska O, Khan SB, Bhangal G, Tasman CH, Saleem MA, Baker DP, Lobb RR, Smith J, Cook HT, Mathieson PW, Pusey CD. Interferon-beta reduces proteinuria in experimental glomerulonephritis. J Am Soc Nephrol 18: 2875-2884, 2007.
21. Segerer S, Banas B, Wörnle M, Schmid H, Cohen CD, Kretzler M, Mack M, Kiss E, Nelson PJ, Schlöndorff D, Gröne HJ. CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis. Am J Pathol 164: 635-649, 2004.
22. Vaidya VS, Waikar SS, Ferguson MA, Collings FB, Sunderland K, Gioules C, Bradwin G, Matsouaka R, Betensky RA, Curhan GC, Bonventre JV. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci 1: 200-208, 2008
23. Vielhauer V, Stavrakis G, Mayadas TN. Renal cell-expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis. J Clin Invest 115: 1199-1209, 2005.
24. Vitour D, Meurs EF. Regulation of interferon production by RIG-I and LGP2: a lesson in self-control. Sci STKE 384: 20, 2007.
25. Wolkow PP, Niewczas MA, Perkins B, Ficociello LH, Lipinski B, Warram JH, Krolewski AS. Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics. J Am Soc Nephrol 19: 789-797, 2008.
26. Wörnle M, Roeder M, Sauter M, Ribeiro A. Role of matrix metalloproteinases in viral-associated glomerulonephritis. Nephrol Dial Transplant 24: 1113-1121, 2009.
27. Wörnle M, Schmid H, Banas B, Merkle M, Henger A, Roeder M, Blattner S, Bock E, Kretzler M, Gröne HJ, Schlöndorff D. Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis. Am J Pathol 168: 370-385, 2006.
28. Wörnle M, Schmid H, Merkle M, Banas B. Effects of chemokines on proliferation and apoptosis of human mesangial cells. BMC Nephrol 5: 8, 2004.
29. Ye L, Wang X, Wang S, Luo G, Wang Y, Liang H, Ho W. Centrifugal enhancement of hepatitis C virus infection of human hepatocytes. J Virol Methods 148: 161-165, 2008.
30. Zeremski M, Petrovic LM, Talal AH. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection. J Viral Hepat 14: 675-687, 2007